Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis

María Muñoz-Hernando,Paula Nogales Gómez-Imaz,Irene Fernández-Barahona,Jesús Ruiz-Cabello,Jacob F Bentzon,Fernando Herranz
DOI: https://doi.org/10.1039/d3nr06507c
IF: 6.7
2024-02-27
Nanoscale
Abstract:Atherosclerosis, a leading cause of cardiovascular diseases requires approaches to enhance disease monitoring and treatment. Nanoparticles offer promising potential in this area by being customisable to target components or molecular processes within plaques, while carrying diagnostic and therapeutic agents. However, the number of biomarkers available to target this disease is limited. This study investigated the use of sphingomyelin-based nanomicelles triggered by sphingomyelinase (SMase) in atherosclerotic plaques. Accumulation of iron oxide-based nanomicelles in the plaque was demonstrated by fluorescence, MR imaging and electron microscopy. These findings demonstrate the possibility of utilising SMase as a mechanism to retain nanoprobes within plaques, thus opening up possibilities for future therapeutic interventions.
materials science, multidisciplinary,physics, applied,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?